Jump to content

Kallikrein-1

From Wikipedia, the free encyclopedia
(Redirected from KLK1)

KLK1
Identifiers
AliasesKLK1, KLKR, Klk6, hK1, kallikrein 1
External IDsOMIM: 147910; MGI: 102850; GeneCards: KLK1
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.4.21.35↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002257

NM_010639
NM_001320331
NM_001320332

RefSeq (protein)

NP_002248

NP_001307260
NP_001307261
NP_034769

Location (UCSC)Chr 19: 50.82 – 50.82 MbChr 7: 43.87 – 43.88 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Kallikrein-1, also called tissue kallikrein, is an protein that in humans is encoded by the KLK1 gene.[5][6][7] This enzyme acts on kininogen to produce Lys-bradykinin as part of the kinin–kallikrein system.[8]

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. This protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.[9]

Medical significance

[edit]

A recombinant form of kallikrein-1, designated as DM199, is being tested as an experimental drug that acts on the kallikrein-kinin system and is developed for diabetes.[10][11][12][13]

See also

[edit]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000167748 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000063903 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Richards RI, Holman K, Shen Y, Kozman H, Harley H, Brook D, et al. (September 1991). "Human glandular Kallikrein genes: genetic and physical mapping of the KLK1 locus using a highly polymorphic microsatellite PCR marker". Genomics. 11 (1): 77–82. doi:10.1016/0888-7543(91)90103-L. PMID 1684954.
  6. ↑ Lundwall A, Band V, Blaber M, Clements JA, Courty Y, Diamandis EP, et al. (June 2006). "A comprehensive nomenclature for serine proteases with homology to tissue kallikreins". Biological Chemistry. 387 (6): 637–641. doi:10.1515/BC.2006.082. PMID 16800724. S2CID 436200.
  7. ↑ "Proceedings of the 1st International Symposium on Kallikreins, Lausanne, Switzerland, September 1-3, 2005". Biological Chemistry. 387 (6): 635–824. June 2006. doi:10.1515/BC.2006.081. PMID 16800723. S2CID 83910246.
  8. ↑ "Kallikrein-1". UniProt consortium. Retrieved 2026-10-21.
  9. ↑ "Entrez Gene: KLK1 kallikrein 1".
  10. ↑ Maneva-Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. (2014). "Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1". PLOS ONE. 9 (9) e107213. Bibcode:2014PLoSO...9j7213M. doi:10.1371/journal.pone.0107213. PMC 4178025. PMID 25259810.
  11. ↑ Charest-Morin X, Raghavan A, Charles ML, Kolodka T, Bouthillier J, Jean M, et al. (March 2015). "Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors". Pharmacology Research & Perspectives. 3 (2) e00119. doi:10.1002/prp2.119. PMC 4448978. PMID 26038695.
  12. ↑ Kolodka T, Charles ML, Raghavan A, Radichev IA, Amatya C, Ellefson J, et al. (2014). "Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus". PLOS ONE. 9 (8) e103981. Bibcode:2014PLoSO...9j3981K. doi:10.1371/journal.pone.0103981. PMC 4123992. PMID 25100328.
  13. ↑ Alexander-Curtis M, Pauls R, Chao J, Volpi JJ, Bath PM, Verdoorn TA (2019). "Human tissue kallikrein in the treatment of acute ischemic stroke". Therapeutic Advances in Neurological Disorders. 12 1756286418821918. doi:10.1177/1756286418821918. PMC 6348491. PMID 30719079.

Further reading

[edit]
[edit]
  • The MEROPS online database for peptidases and their inhibitors: S01.160